AIRLINK 70.80 Decreased By ▼ -2.26 (-3.09%)
BOP 4.98 Decreased By ▼ -0.11 (-2.16%)
CNERGY 4.32 Decreased By ▼ -0.05 (-1.14%)
DFML 31.39 Decreased By ▼ -1.06 (-3.27%)
DGKC 76.80 Increased By ▲ 1.31 (1.74%)
FCCL 20.05 Increased By ▲ 0.53 (2.72%)
FFBL 35.19 Decreased By ▼ -0.96 (-2.66%)
FFL 9.15 Decreased By ▼ -0.07 (-0.76%)
GGL 9.89 Increased By ▲ 0.04 (0.41%)
HBL 113.47 Decreased By ▼ -3.23 (-2.77%)
HUBC 132.79 Increased By ▲ 0.10 (0.08%)
HUMNL 7.10 No Change ▼ 0.00 (0%)
KEL 4.33 Decreased By ▼ -0.08 (-1.81%)
KOSM 4.35 Decreased By ▼ -0.05 (-1.14%)
MLCF 36.75 Increased By ▲ 0.55 (1.52%)
OGDC 134.00 Increased By ▲ 0.50 (0.37%)
PAEL 22.45 Decreased By ▼ -0.15 (-0.66%)
PIAA 24.75 Decreased By ▼ -1.26 (-4.84%)
PIBTL 6.52 Decreased By ▼ -0.03 (-0.46%)
PPL 117.80 Increased By ▲ 2.49 (2.16%)
PRL 26.32 Decreased By ▼ -0.31 (-1.16%)
PTC 13.80 Decreased By ▼ -0.30 (-2.13%)
SEARL 52.50 Decreased By ▼ -0.95 (-1.78%)
SNGP 68.90 Increased By ▲ 1.65 (2.45%)
SSGC 10.68 Decreased By ▼ -0.02 (-0.19%)
TELE 8.48 Increased By ▲ 0.06 (0.71%)
TPLP 10.90 Increased By ▲ 0.15 (1.4%)
TRG 61.33 Decreased By ▼ -2.54 (-3.98%)
UNITY 25.13 Increased By ▲ 0.01 (0.04%)
WTL 1.28 Increased By ▲ 0.01 (0.79%)
BR100 7,450 Decreased By -11.3 (-0.15%)
BR30 24,143 Decreased By -28.7 (-0.12%)
KSE100 71,151 Increased By 48.9 (0.07%)
KSE30 23,403 Increased By 8.4 (0.04%)
Business & Finance

Moderna sees $18.4bn in sales from COVID-19 vaccine in 2021

  • Moderna also said Chief Medical Officer Tal Zaks would leave the company in late September.
  • Moderna on Wednesday said it was expecting to produce 700 million doses in 2021, while attempting to scale up production to as much as 1 billion doses.
Published February 25, 2021

Moderna Inc said on Thursday it was expecting to post $18.4 billion in sales from its COVID-19 vaccine this year.

Pfizer Inc, which makes the only other vaccine authorized for emergency use in the United States so far, said earlier this month that it was expecting to record sales of about $15 billion in 2021 from the coronavirus vaccine that it makes with German partner BioNTech.

Moderna also said Chief Medical Officer Tal Zaks would leave the company in late September.

Moderna on Wednesday said it was expecting to produce 700 million doses in 2021, while attempting to scale up production to as much as 1 billion doses.

Comments

Comments are closed.